Assays for the Screening and Characterization of Tau Aggregation Inhibitors

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Aggregation of tau protein is a pathological hallmark of Alzheimer's disease and other neurodegenerative tauopathies. Inhibition of tau aggregation could provide a method for the treatment of these disorders. Methods to identify tau aggregation inhibitors (TAIs) in vitro are useful and here we describe assays for TAIs using purified recombinant tau protein fragments in a cell-free immunoassay format and a stably transfected cell model to create a more physiological environment.

Original languageEnglish
Title of host publicationTau Protein
Subtitle of host publicationMethods and Protocols
EditorsCaroline Smet-Nocca
PublisherSpringer
Pages129-140
Number of pages12
Volume1523
ISBN (Electronic)978-1-4939-6598-4
ISBN (Print)978-1-4939-6596-0
DOIs
Publication statusPublished - 15 Dec 2016

Publication series

NameMethods in Molecular Biology
PublisherSpringer
Volume1523
ISSN (Print)1064-3745

    Fingerprint

Keywords

  • Alzheimer's disease
  • ELISA
  • immunoassay
  • tau protein
  • tau aggregation inhibitor

Cite this

Rickard, J. E., Horsley, D., Wischik, C. M., & Harrington, C. R. (2016). Assays for the Screening and Characterization of Tau Aggregation Inhibitors. In C. Smet-Nocca (Ed.), Tau Protein: Methods and Protocols (Vol. 1523, pp. 129-140). (Methods in Molecular Biology; Vol. 1523). Springer . https://doi.org/10.1007/978-1-4939-6598-4_8